{"id":25984,"date":"2025-10-20T15:45:30","date_gmt":"2025-10-20T15:45:30","guid":{"rendered":"https:\/\/cpata-cabamc.ca\/?page_id=25984"},"modified":"2025-10-20T15:50:44","modified_gmt":"2025-10-20T15:50:44","slug":"guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents","status":"publish","type":"page","link":"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/","title":{"rendered":"Guidelines regarding the Standard of Due Care \u2013 the Impact of Recent Federal Court Decisions for both Patent Agents and Trademark Agents"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"25984\" class=\"elementor elementor-25984\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6599448 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6599448\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-dcfbfbf\" data-id=\"dcfbfbf\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d1483b7 elementor-widget elementor-widget-text-editor\" data-id=\"d1483b7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span data-contrast=\"none\">The due care standard is mandated in the <\/span><i><span data-contrast=\"none\">Patent Act<\/span><\/i><span data-contrast=\"none\">. However, the decisions of the Federal Courts interpreting and applying the due care standard are worthy of consideration by both patent agents and trademark agents because these decisions enunciate a number of relevant practice standards for both professions.<\/span><span data-contrast=\"none\">\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335557856&quot;:16777215,&quot;335559739&quot;:173,&quot;335559740&quot;:278}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The purpose of this article is to provide some general guidance to licensees about the current status of the due care standard, together with some relevant factors to consider, as articulated by the Federal Court of Appeal and in the CPATA Code of Professional Conduct for Patent Agents and Trademark Agents. This guidance does not replace licensees\u2019 own obligations to exercise sound professional judgement at all times in each matter in your clients\u2019 best interests.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335557856&quot;:16777215,&quot;335559739&quot;:173,&quot;335559740&quot;:278}\">\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-503cc7a elementor-widget elementor-widget-text-editor\" data-id=\"503cc7a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3><strong><u>The Due Care Standard in the <em>Patent Act<\/em><\/u><\/strong><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3737f14 elementor-widget elementor-widget-text-editor\" data-id=\"3737f14\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Under the <em>Patent Act<\/em>, failure to pay a patent or patent application maintenance fee or failure to request examination by its prescribed due date triggers the sending of a Commissioner\u2019s Notice establishing a due date for taking missed action(s), together with payment of a late fee. The patentee or applicant must meet the due date set by the Notice to avoid deemed expiry of the patent or deemed abandonment of the application. A patent that is deemed expired or an application deemed abandoned resulting from a failure to meet the Notice due date <em>may<\/em> have its deemed expiry reversed or be reinstated on request, if the Commissioner determines that the failure occurred in spite of the required due care having been taken<strong>. <\/strong>In the case of deemed abandonment resulting from a failure to request examination, the due care requirement only applies if the request for reinstatement is submitted more than 6 months after the original prescribed due date.<\/p><p>CIPO has adopted a high standard when evaluating whether due care has been taken in each case. Fewer than 15% of over 300 CIPO final determinations since 2019 have concluded with a finding that due care was, in fact, taken. According to CIPO\u2019s published observations about the various reasons the due care standard was not found to have been met in many cases, these include:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2d867f8 elementor-widget elementor-widget-text-editor\" data-id=\"2d867f8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ol><li><strong>Relevant point in time<\/strong> &#8211; Many requests for reinstatement or reversal of expiry fail to provide an explanation of what was done after the Commissioner\u2019s Notice was received. If the request for reinstatement or reversal of deemed expiry focuses on the reasons why the original due date was missed, the Commissioner will not be able to make a determination that the failure occurred in spite of the due care required by the circumstances having been taken.<\/li><li><strong>Unintentionality <\/strong>\u2013 It is mistakenly assumed by some applicants and patentees that it is sufficient to explain that the due date set by a Commissioner\u2019s Notice was missed unintentionally. The \u201cunintentional\u201d requirement only applies to restoration of the right of priority, late national phase entry, and certain extensions of time.<\/li><li><strong>All authorized persons must take due care<\/strong> \u2013 as we will see from the jurisprudence, all persons that were authorized by the applicant or patentee must take due care to ensure that the relevant action and payment of the late fee are completed before the Commissioner\u2019s Notice due date. For example, if a foreign patentee instructs their local agent to retain a Canadian patent agent to represent them before CIPO, but hires an annuity firm to pay the maintenance fees, the patentee, patent agents (both local and Canadian), and annuity firm must all demonstrate that the required due care was taken. The Canadian agent may be operating under a limited scope retainer since they are not responsible for monitoring maintenance fee deadlines or paying the fees, but when a Notice is received, they agent may still need to forward the Notice to the appropriate party.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-91ad8a6 elementor-widget elementor-widget-text-editor\" data-id=\"91ad8a6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The Federal Court of Appeal has now issued two key decisions relating to the standard of care: <a href=\"https:\/\/canlii.ca\/t\/k999r\"><em>Taillefer v. Canada (Attorney General),<\/em> 2025 FCA 28<\/a>, and <a href=\"https:\/\/www.canlii.org\/en\/ca\/fca\/doc\/2025\/2025fca156\/2025fca156.html\"><em>Canada (Attorney General) v. Matco Tools Corporation,<\/em> 2025 FCA 156<\/a>.\u00a0 The decisions demonstrate how the Commissioner and courts are continuing to work through the rationale and parameters of what due care is required, and that the courts are setting a high bar for those seeking to rely on the due care standard.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-212779e elementor-widget elementor-widget-text-editor\" data-id=\"212779e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>The <em>Taillefer <\/em>Decision <\/strong>(<em>Taillefer v. Canada (Attorney General),<\/em> 2025 FCA 28)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1d9eb37 elementor-widget elementor-widget-text-editor\" data-id=\"1d9eb37\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>A patent agent had established a routine of communicating with his client, the patentee, by email to obtain instructions respecting payment of annual maintenance fees. At some point, the patentee\u2019s email filter started routing the agent\u2019s maintenance fee emails to the patentee\u2019s junk mail folder, where they were discovered some time after the patent was deemed expired. The Commissioner refused to reverse the deemed expiry, finding that the agent and the client had failed to exercise due care by ensuring they had an effective means for communicating in place.\u00a0<\/p><p>On application for judicial review by the applicant, the Federal Court upheld the Commissioner\u2019s determination and concluded that it was reasonable for Commissioner to have expected the patentee to ensure that the communication system between themselves and their agent was working so that reporting could be made and instructions given, and that both the patentee and agent should have considered steps that could have avoided the communication failure. The Court agreed with the Commissioner that agents should have appropriate communication mechanisms in place to ensure they are always able to communicate effectively with their clients. With the Federal Court of Appeal\u2019s dismissal of the patentee\u2019s appeal, the <em>Taillefer <\/em>decision stands and confirms that those relying on the due care provisions of the <em>Patent Act<\/em> must maintain reliable principal and backup communication channels to avoid, in the Federal Court of Appeal\u2019s words, \u201can accident waiting to happen\u201d. The bottom line is that if you get radio silence in response to your primary communication method with your client, you MUST try another way.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-aed074c elementor-widget elementor-widget-text-editor\" data-id=\"aed074c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>The <em>Matco Tools<\/em> Decision <\/strong>(<em>C<\/em>anada<em> (Attorney General) v. Matco Tools Corporation,<\/em> 2025 FCA 156)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3bcdbb7 elementor-widget elementor-widget-text-editor\" data-id=\"3bcdbb7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>As is often the case with Canadian patent applications, the applicant relied on multiple parties to handle different aspects of its patent application, including a Canadian patent agent as the representative before CIPO, local (US) counsel, and an annuity service provider. As the applicant had engaged the annuity service provider, they instructed US counsel to take no further action regarding payment of maintenance fees. US counsel in turn advised the Canadian agent that maintenance fees would be handled by a third party.<\/p><p>However, due to a data migration error when the annuity service provider assumed responsibility for the applicant\u2019s portfolio, this particular application was accidentally omitted, ultimately resulting in a missed maintenance fee payment. A Commissioner\u2019s Notice regarding the non-payment was received by the Canadian agent, who forwarded it to US counsel. Because US counsel had been given instructions to take no further action relating to maintenance fees, they did not send the Notice to the applicant. As the applicant was unaware of the default, the maintenance fee went unpaid, and the application was deemed abandoned.<\/p><p>The Commissioner refused to reinstate the application, finding that (1) the data migration error that gave rise to the missed anniversary due date was irrelevant to the due care analysis, since abandonment could have been avoided by proper handling of the Commissioner\u2019s Notice; (2) no satisfactory explanation was given for US counsel\u2019s failure to forward the Notice; and (3) there was insufficient evidence that the applicant had implemented sufficient safeguards such as adequate staff training, effective monitoring systems, or verification and quality control methods.<\/p><p>The Federal Court granted judicial review to the applicant, but this was overturned on appeal because the Court had failed to defer to the Commissioner\u2019s reasoning, and the Commissioner\u2019s due care analysis was reasonable. In allowing the Commissioner\u2019s appeal, the Federal Court of Appeal provided useful interpretive guidance to agents and clients:<\/p><ul><li>The <em>Patent Act<\/em> requires an applicant to provide the reasons for the failure to take the action that should have been taken to avoid abandonment; in this case, the action that should have been taken was payment of the maintenance fee and late fee by the due date set by the Commissioner\u2019s Notice. It was therefore appropriate for the Commissioner to disregard the circumstances surrounding the missed anniversary due date and to focus on events occurring after the Notice was sent.<\/li><li>To have practical effect, the duty to exercise due care must apply to the recipient of a Commissioner\u2019s Notice. A patent agent who is appointed in respect of a patent application is the designated point of contact for CIPO, and therefore the duty to exercise due care applies to them.<\/li><\/ul><p>The Federal Court of Appeal also provided guidance to patent agents who are instructed by intermediaries and\/or operating under a limited scope retainer, such as in the <em>Matco <\/em>scenario. There may be situations where the appointed Canadian agent must forward Commissioner\u2019s Notices, even if they had been instructed not to do so. At paragraphs 45-48 of the decision, the Federal Court of Appeal discussed the obligations of the Canadian agent and US counsel:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-545054f elementor-widget elementor-widget-text-editor\" data-id=\"545054f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"padding-left: 40px;\">[45] Moreover, the answer to the further question of whether the obligation to exercise due care extended to Matco\u2019s other representatives, such as Hahn [the US counsel], does not assist Matco. If Hahn was not subject to the due care obligation, then the question would become whether Ridout [the Canadian agent] exercised due care in sending the Notice to Hahn only, and not to Matco. As stated in the Commissioner\u2019s Decision, and in MOPOP, Chapter 9.04.03, the question of the exercise of due care turns on whether the applicant (or in this case, its agent) \u201ctook all measures that a reasonably prudent applicant would have taken\u201d. It is difficult to imagine that Ridout could meet this requirement by forwarding the Notice to someone who was not Matco (the applicant) and who had no obligation themselves to advise Matco of the Notice. Ridout indicated that it had no direct contact with Matco, and this was the reason that it forwarded the Notice to Hahn. But a prudent agent would do so only if it expected that Hahn would ensure that Matco was made aware of the Notice.<\/p><p style=\"padding-left: 40px;\">[46] In the end, either Hahn failed to exercise due care by not forwarding the Notice to Matco, or Ridout failed to exercise due care by forwarding the Notice to someone who could not be expected to forward it to Matco.<\/p><p style=\"padding-left: 40px;\">[48] Though the Commissioner\u2019s Decision does not provide much reasoning for imposing the due care obligation on agents and other representatives, the MOPOP and the WIPO Guidelines do. As alluded to above, Chapter 5.08 of the MOPOP indicates that correspondence to an applicant will be sent to its patent agent when one has been appointed. It stands to reason that that agent is expected, at a minimum, to forward such correspondence to the applicant for their action. It also stands to reason that sending such correspondence to an applicant\u2019s US counsel (instead of to the applicant itself) would constitute due care only if that US counsel had an attendant duty at least to forward it to the applicant.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-480cb62 elementor-widget elementor-widget-text-editor\" data-id=\"480cb62\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3><strong><u>Key Takeaways from these Decisions <\/u><\/strong><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7743819 elementor-widget elementor-widget-text-editor\" data-id=\"7743819\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Both Federal Court of Appeal decisions define a basic requirement of the due care standard: an appointed Canadian patent agent is expected to forward a Commissioner\u2019s Notice, or at least report the event to the instructing party. Further, Canadian patent agents must take steps to be assured that the ultimate applicant or patentee gets the message, although the steps that should be taken will depend on the circumstances.<\/p><p>It is still unclear from the case law what level of explanation needs to be provided to the instructing party, patentee, or applicant, but doing nothing in view of the restrictions of a limited retainer likely will not be enough.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fc9c2e9 elementor-widget elementor-widget-text-editor\" data-id=\"fc9c2e9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Is there a Trademark Agency Equivalent to the Due Care Standard?<\/strong><\/p><p><span class=\"TextRun SCXW102479152 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW102479152 BCX0\">Trademark law does not include a statutory due care provision or <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">rules <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">for missed deadlines or reinstatement in the same way as for patent applications.<\/span> <span class=\"NormalTextRun SCXW102479152 BCX0\">However, the general principles <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">referenced<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\"> by the Federal Courts should be considered by trademark agents too.<\/span> <span class=\"NormalTextRun SCXW102479152 BCX0\">Maintenance fee <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">requirements <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">in patent law are similar in nature to the renewal provisions for trademarks in that when <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">an initial<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\"> or renewal period expires without payment, the Registrar <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">is required to<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\"> send a notice <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">establishing<\/span> <span class=\"NormalTextRun SCXW102479152 BCX0\">a late payment<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\"> due date. <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">The principles arising from the <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">interpretation of the <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">due care standard <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">therefore <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">provide<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\"> helpful guidance<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\"> to trademark renewals<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">. <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">More<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">over, the due care requirements are<\/span> <span class=\"NormalTextRun SCXW102479152 BCX0\">consistent with the general <\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">requirements of the<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\"> CPATA<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\"> Code of Professional C<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">onduct<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">, as described further in the following section<\/span><span class=\"NormalTextRun SCXW102479152 BCX0\">.\u00a0<\/span><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ee62a52 elementor-widget elementor-widget-text-editor\" data-id=\"ee62a52\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong><span class=\"TextRun SCXW60138446 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW60138446 BCX0\">The CPATA Code of Professional Conduct for Patent Agents and Trademark Agents<\/span><\/span><span class=\"EOP SCXW60138446 BCX0\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:278}\">\u00a0<\/span><\/strong><\/p><p>The CPATA Code of Conduct provides helpful guidance to support patent agents and trademark agents in maintaining appropriate practice standards to avoid the circumstances that gave rise to the decisions above.<\/p><ol><li><em>Part 1 Competence<\/em> \u2013 this Rule establishes a duty to pay attention to the interests of your clients and implement appropriate records, systems and procedures in \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 order to conduct your professional business (Rule 1(2)(a). Rule 1(4) provides:<\/li><\/ol><p style=\"padding-left: 40px;\">\u201cAn agent must maintain appropriate office procedures and systems, including systems for meeting the requirements for all deadlines arising from client matters and for handling and maintaining client affairs without prejudicing them.\u201d<\/p><ol start=\"2\"><li><em>Part 4 Quality of Service<\/em> \u2013 this Rule provides that:<\/li><\/ol><p style=\"padding-left: 40px;\">\u201cAn agent has a duty to communicate effectively with the client.\u00a0 What is effective will vary depending on the nature of the retainer, the needs and sophistication of the client and the need for the client to make fully informed decisions and provide instructions.\u201d<\/p><p style=\"padding-left: 40px;\">Commentary 4(6) adds that \u201cAn agent must communicate in a timely and effective manner at all stages of a client&#8217;s matter or transaction.\u201d<\/p><ol start=\"3\"><li><em>Part 6 Withdrawal of Services<\/em> \u2013 this Rule addresses the circumstance where an agent withdraws or is discharged from a matter. When an agent is instructed that they are not responsible for maintenance or renewals, they have been effectively discharged from that aspect of the matter, even if they remain the agent of record for other purposes.<\/li><\/ol><p style=\"padding-left: 40px;\">Rule 6(5) provides that when an agent withdraws or is discharged from a matter, but receives an official communication to which a response must be filed to avoid abandonment, the agent must still endeavour to report the official communication in a timely manner so as to avoid prejudice to the client, and to permit the client to take appropriate steps to safeguard their rights.<\/p><p>Clearly, there is a close correlation between the due care standard set by CIPO, the Federal Courts, and the CPATA Code of Conduct.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-25e964e elementor-widget elementor-widget-text-editor\" data-id=\"25e964e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Practice Tips<\/strong><\/p><p>Managing key deadlines, particularly relating to payment of fees, is essential to a patent or trademark agent\u2019s practice. Here are a few practice tips that may help you in this regard:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fa13566 elementor-widget elementor-widget-text-editor\" data-id=\"fa13566\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Obtain full contact information including mailing address, email addresses and all phone numbers from clients at the outset of your retainer to ensure effective communications can always be maintained. Make it clear to clients that it is their responsibility to update you if their contact information changes.<\/li><li>Enter into written retainer agreements with clients that set expectations regarding communications and that emphasize why it is important that you effectively communicate with each other, and what may happen if you don\u2019t.<\/li><li>Confirm all client instructions in writing, including directions about who will provide you with instructions, to whom you must report, and the methods of communication, and any changes to those directions.<\/li><li>Similarly, confirm client instructions in writing concerning your role in tracking, reminding about, and paying maintenance and renewal fees. In the case of patents, re-confirm those responses at issuance, as some clients may wish to move responsibility from the agent to an annuity service provider at that stage. State what steps you will and will not take if a client fails to provide instructions and\/or makes required payments, and the risk and consequences of abandonment.<\/li><li>In situations where you are having trouble obtaining instructions from a client through your regular method of communication, try reaching out by alternate means. If the client is unresponsive to email, consider phoning or mailing the client to seek instructions. Don\u2019t assume that silence is intentional!<\/li><li>When you are the agent of record, you have an important role to play in ensuring that deadlines are met. A good practice is to alert the applicant, patentee, or registrant (directly or through an instructing party) of any due date-setting notice from CIPO.<\/li><li>Agents acting under a limited scope retainer should recognize that when serving as agents of record, they may be required to take steps that might be beyond the scope of the retainer in certain situations. In cases where agents are not responsible for payment of fees, should the agent of record receive a notice, doing nothing will not suffice. As noted above, while a good practice is to alert the patentee or registrant, the methods for attempting to do so will depend on the situation. Agents of record caught in such situations can consider making an <a href=\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethics-inquiries\/\">Ethics Inquiry<\/a> to CPATA. Agents of record might also consider reaching out to their professional liability insurer to determine whether they have specific guidance for your situation.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-85b9b13 elementor-widget elementor-widget-text-editor\" data-id=\"85b9b13\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>As always, these guidelines are provided by CPATA solely as an additional resource for licensees to consider and should not be relied upon to replace licensee\u2019s own professional judgment in all relevant circumstances.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>The due care standard is mandated in the Patent Act. However, the decisions of the<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":19280,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"full-width-container","site-content-style":"unboxed","site-sidebar-style":"unboxed","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"folder":[],"class_list":["post-25984","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Guidelines regarding the Standard of Due Care \u2013 the Impact of Recent Federal Court Decisions for both Patent Agents and Trademark Agents - CPATA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guidelines regarding the Standard of Due Care \u2013 the Impact of Recent Federal Court Decisions for both Patent Agents and Trademark Agents - CPATA\" \/>\n<meta property=\"og:description\" content=\"The due care standard is mandated in the Patent Act. However, the decisions of the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/\" \/>\n<meta property=\"og:site_name\" content=\"CPATA\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-20T15:50:44+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"13 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/\",\"url\":\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/\",\"name\":\"Guidelines regarding the Standard of Due Care \u2013 the Impact of Recent Federal Court Decisions for both Patent Agents and Trademark Agents - CPATA\",\"isPartOf\":{\"@id\":\"https:\/\/cpata-cabamc.ca\/en\/#website\"},\"datePublished\":\"2025-10-20T15:45:30+00:00\",\"dateModified\":\"2025-10-20T15:50:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cpata-cabamc.ca\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Your Practice\",\"item\":\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Professional Conduct\",\"item\":\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Ethical Analyses and Guidance\",\"item\":\"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"Guidelines regarding the Standard of Due Care \u2013 the Impact of Recent Federal Court Decisions for both Patent Agents and Trademark Agents\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cpata-cabamc.ca\/en\/#website\",\"url\":\"https:\/\/cpata-cabamc.ca\/en\/\",\"name\":\"CPATA\",\"description\":\"CPATA\",\"publisher\":{\"@id\":\"https:\/\/cpata-cabamc.ca\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cpata-cabamc.ca\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cpata-cabamc.ca\/en\/#organization\",\"name\":\"CPATA\",\"url\":\"https:\/\/cpata-cabamc.ca\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cpata-cabamc.ca\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cpata-cabamc.ca\/wp-content\/uploads\/2021\/02\/Logo-Light-RGB.svg\",\"contentUrl\":\"https:\/\/cpata-cabamc.ca\/wp-content\/uploads\/2021\/02\/Logo-Light-RGB.svg\",\"width\":561,\"height\":112,\"caption\":\"CPATA\"},\"image\":{\"@id\":\"https:\/\/cpata-cabamc.ca\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Guidelines regarding the Standard of Due Care \u2013 the Impact of Recent Federal Court Decisions for both Patent Agents and Trademark Agents - CPATA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/","og_locale":"en_US","og_type":"article","og_title":"Guidelines regarding the Standard of Due Care \u2013 the Impact of Recent Federal Court Decisions for both Patent Agents and Trademark Agents - CPATA","og_description":"The due care standard is mandated in the Patent Act. However, the decisions of the","og_url":"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/","og_site_name":"CPATA","article_modified_time":"2025-10-20T15:50:44+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"13 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/","url":"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/","name":"Guidelines regarding the Standard of Due Care \u2013 the Impact of Recent Federal Court Decisions for both Patent Agents and Trademark Agents - CPATA","isPartOf":{"@id":"https:\/\/cpata-cabamc.ca\/en\/#website"},"datePublished":"2025-10-20T15:45:30+00:00","dateModified":"2025-10-20T15:50:44+00:00","breadcrumb":{"@id":"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/guidelines-regarding-the-standard-of-due-care-the-impact-of-recent-federal-court-decisions-for-both-patent-agents-and-trademark-agents\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cpata-cabamc.ca\/en\/"},{"@type":"ListItem","position":2,"name":"Your Practice","item":"https:\/\/cpata-cabamc.ca\/en\/your-practice\/"},{"@type":"ListItem","position":3,"name":"Professional Conduct","item":"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/"},{"@type":"ListItem","position":4,"name":"Ethical Analyses and Guidance","item":"https:\/\/cpata-cabamc.ca\/en\/your-practice\/professional-conduct\/ethical-analyses-and-guidance\/"},{"@type":"ListItem","position":5,"name":"Guidelines regarding the Standard of Due Care \u2013 the Impact of Recent Federal Court Decisions for both Patent Agents and Trademark Agents"}]},{"@type":"WebSite","@id":"https:\/\/cpata-cabamc.ca\/en\/#website","url":"https:\/\/cpata-cabamc.ca\/en\/","name":"CPATA","description":"CPATA","publisher":{"@id":"https:\/\/cpata-cabamc.ca\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cpata-cabamc.ca\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cpata-cabamc.ca\/en\/#organization","name":"CPATA","url":"https:\/\/cpata-cabamc.ca\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cpata-cabamc.ca\/en\/#\/schema\/logo\/image\/","url":"https:\/\/cpata-cabamc.ca\/wp-content\/uploads\/2021\/02\/Logo-Light-RGB.svg","contentUrl":"https:\/\/cpata-cabamc.ca\/wp-content\/uploads\/2021\/02\/Logo-Light-RGB.svg","width":561,"height":112,"caption":"CPATA"},"image":{"@id":"https:\/\/cpata-cabamc.ca\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cpata-cabamc.ca\/en\/wp-json\/wp\/v2\/pages\/25984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cpata-cabamc.ca\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cpata-cabamc.ca\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cpata-cabamc.ca\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/cpata-cabamc.ca\/en\/wp-json\/wp\/v2\/comments?post=25984"}],"version-history":[{"count":0,"href":"https:\/\/cpata-cabamc.ca\/en\/wp-json\/wp\/v2\/pages\/25984\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/cpata-cabamc.ca\/en\/wp-json\/wp\/v2\/pages\/19280"}],"wp:attachment":[{"href":"https:\/\/cpata-cabamc.ca\/en\/wp-json\/wp\/v2\/media?parent=25984"}],"wp:term":[{"taxonomy":"folder","embeddable":true,"href":"https:\/\/cpata-cabamc.ca\/en\/wp-json\/wp\/v2\/folder?post=25984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}